Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Al.3F |
| Molecular Weight | 83.9767 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[F-].[F-].[F-].[Al+3]
InChI
InChIKey=KLZUFWVZNOTSEM-UHFFFAOYSA-K
InChI=1S/Al.3FH/h;3*1H/q+3;;;/p-3
| Molecular Formula | FH |
| Molecular Weight | 20.0063 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Al |
| Molecular Weight | 26.9815 |
| Charge | 3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: Description was created based on several sources, including
https://www.google.com/patents/US2824042 | https://www.ncbi.nlm.nih.gov/pubmed/22718290 | https://www.ncbi.nlm.nih.gov/pubmed/15516810 | https://www.ncbi.nlm.nih.gov/pubmed/10211213 | https://www.drugs.com/monograph/aluminum-acetate.html
Curator's Comment: Description was created based on several sources, including
https://www.google.com/patents/US2824042 | https://www.ncbi.nlm.nih.gov/pubmed/22718290 | https://www.ncbi.nlm.nih.gov/pubmed/15516810 | https://www.ncbi.nlm.nih.gov/pubmed/10211213 | https://www.drugs.com/monograph/aluminum-acetate.html
Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum sulfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate.
The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2364031 |
|||
Target ID: GO:0042310 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | DOMEBORO Approved UseTemporarily relieves minor skin irritations due to:
– Poison ivy | – Poison oak
– Poison sumac | – Insect bites
– Athlete’s foot | – Rashes caused by soaps, detergents, cosmetics, or jewelry |
|||
| Curative | DOMEBORO Approved UseThis medication is used to treat an outer ear infection (external otitis). This product contains acetic acid/aluminum acetate, a combination that stops the growth of bacteria and fungus. Treating the infection reduces pain and swelling in the ear. Wetness in the ear canal can help bacteria and fungus to grow. This medication also causes drying of the ear canal, helping to cure the infection. |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Aluminum fluoride induces phosphatidylinositol turnover, elevation of cytoplasmic free calcium, and phosphorylation of the T cell antigen receptor in murine T cells. | 1987 Nov 15 |
|
| Cardiovascular manifestations of aluminium phosphide intoxication. | 1989 Sep |
|
| Plasma renin activity in shock due to aluminium phosphide poisoning. | 1990 Jun |
|
| Hypermagnesemia following aluminum phosphide poisoning. | 1991 Feb |
|
| Requirement for intramolecular domain interaction in activation of G protein alpha subunit by aluminum fluoride and GDP but not by GTP gamma S. | 1994 Nov 25 |
|
| Effect of aluminum phosphide on blood glucose level. | 1999 Feb |
|
| Effects of trace metal compounds on HIV-1 reverse transcriptase: an in vitro study. | 1999 May |
|
| Intravascular hemolysis in aluminium phosphide poisoning. | 1999 Sep |
|
| Effect of N-acetylcysteine and L-NAME on aluminium phosphide induced cardiovascular toxicity in rats. | 2001 Apr |
|
| Cholinesterase inhibition by aluminium phosphide poisoning in rats and effects of atropine and pralidoxime chloride. | 2001 Jan |
|
| Parenteral nutrition-associated cholestasis in neonates: the role of aluminum. | 2003 Sep |
|
| [Pharmaceutical and pharmacological evaluation of Burow's solution (aluminum acetate solution), hospital preparation, and development of its rapid preparation method]. | 2004 Nov |
|
| Aluminum: new recognition of an old problem. | 2005 Dec |
|
| Cytochrome-c oxidase inhibition in 26 aluminum phosphide poisoned patients. | 2006 |
|
| An effector domain mutant of Arf6 implicates phospholipase D in endosomal membrane recycling. | 2006 Jan |
|
| Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents. | 2006 Nov |
|
| Aluminum and Alzheimer's disease: a new look. | 2006 Nov |
|
| Mechanisms of aluminum-induced neurodegeneration in animals: Implications for Alzheimer's disease. | 2006 Nov |
|
| Ototoxic effect of Burow solution applied to the guinea pig middle ear. | 2007 Aug |
|
| Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine. | 2007 Oct |
|
| Reversible myocardial injury associated with aluminum phosphide poisoning. | 2007 Sep |
|
| Hyperglycemia in acute aluminum phosphide poisoning as a potential prognostic factor. | 2008 Jul |
|
| Aluminum phosphide fatalities at mild exertion in asymptomatic children: a clue to understand the variations of the autopsy findings. | 2009 Aug |
|
| Altered glucose homeostasis in response to aluminium phosphide induced cellular oxygen deficit in rat. | 2010 Jul |
|
| Blood levels of methemoglobin in patients with aluminum phosphide poisoning and its correlation with patient's outcome. | 2011 Mar |
|
| Effect of acute aluminum phosphide exposure on rats: a biochemical and histological correlation. | 2012 Nov 23 |
|
| Gene expression profile of mouse fibroblasts exposed to a biodegradable iron alloy for stents. | 2013 Nov |
|
| 1H NMR spectroscopic analysis detects metabolic disturbances in rat urine on acute exposure to heavy metal tungsten alloy based metals salt. | 2014 Mar 25 |
|
| Pesticide exposure and depression among male private pesticide applicators in the agricultural health study. | 2014 Sep |
|
| Molecular basis of carcinogenicity of tungsten alloy particles. | 2015 Mar 15 |
Sample Use Guides
DOMEBORO® SOOTHING SOAK
– dissolve 1 to 3 packets in a pint (16 oz) of cool or warm water
– stir until fully dissolved; do not strain or filter. The resulting mixture contains 0.16% (1 packet), 0.32% (2 packets), or 0.48% (3 packets) aluminum acetate and is ready for use
For use as a soak:
– soak affected area for 15 to 30 minutes as needed, or as directed by a doctor
– repeat 3 times a day or as directed by a doctor
– discard solution after each use.
For use as a compress or wet dressing:
– soak a clean, soft cloth in the solution.
– apply cloth loosely to affected area for 15 to 30 minutes
– repeat as needed or as directed by a doctor
– discard solution after each use
Route of Administration:
Topical
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:54:45 UTC 2023
by
admin
on
Fri Dec 15 18:54:45 UTC 2023
|
| Record UNII |
Z77H3IKW94
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Aluminum fluoride
Created by
admin on Fri Dec 15 18:54:45 UTC 2023 , Edited by admin on Fri Dec 15 18:54:45 UTC 2023
|
PRIMARY | |||
|
2124
Created by
admin on Fri Dec 15 18:54:45 UTC 2023 , Edited by admin on Fri Dec 15 18:54:45 UTC 2023
|
PRIMARY | |||
|
49464
Created by
admin on Fri Dec 15 18:54:45 UTC 2023 , Edited by admin on Fri Dec 15 18:54:45 UTC 2023
|
PRIMARY | |||
|
Z77H3IKW94
Created by
admin on Fri Dec 15 18:54:45 UTC 2023 , Edited by admin on Fri Dec 15 18:54:45 UTC 2023
|
PRIMARY | |||
|
Z77H3IKW94
Created by
admin on Fri Dec 15 18:54:45 UTC 2023 , Edited by admin on Fri Dec 15 18:54:45 UTC 2023
|
PRIMARY | |||
|
DTXSID8030712
Created by
admin on Fri Dec 15 18:54:45 UTC 2023 , Edited by admin on Fri Dec 15 18:54:45 UTC 2023
|
PRIMARY | |||
|
600
Created by
admin on Fri Dec 15 18:54:45 UTC 2023 , Edited by admin on Fri Dec 15 18:54:45 UTC 2023
|
PRIMARY | |||
|
7784-18-1
Created by
admin on Fri Dec 15 18:54:45 UTC 2023 , Edited by admin on Fri Dec 15 18:54:45 UTC 2023
|
PRIMARY | |||
|
232-051-1
Created by
admin on Fri Dec 15 18:54:45 UTC 2023 , Edited by admin on Fri Dec 15 18:54:45 UTC 2023
|
PRIMARY | |||
|
C032311
Created by
admin on Fri Dec 15 18:54:45 UTC 2023 , Edited by admin on Fri Dec 15 18:54:45 UTC 2023
|
PRIMARY | |||
|
m1605
Created by
admin on Fri Dec 15 18:54:45 UTC 2023 , Edited by admin on Fri Dec 15 18:54:45 UTC 2023
|
PRIMARY | Merck Index | ||
|
2273602
Created by
admin on Fri Dec 15 18:54:45 UTC 2023 , Edited by admin on Fri Dec 15 18:54:45 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
